| 000 | 01731 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513113804.0 | ||
| 264 | 0 | _c19970428 | |
| 008 | 199704s 0 0 eng d | ||
| 022 | _a0022-3042 | ||
| 024 | 7 |
_a10.1046/j.1471-4159.1997.68041495.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKuhn, D M | |
| 245 | 0 | 0 |
_aInactivation of tryptophan hydroxylase by nitric oxide: enhancement by tetrahydrobiopterin. _h[electronic resource] |
| 260 |
_bJournal of neurochemistry _cApr 1997 |
||
| 300 |
_a1495-502 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 |
_aBiopterins _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCatalase _xpharmacology |
| 650 | 0 | 4 |
_aDiethylamines _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFree Radical Scavengers _xpharmacology |
| 650 | 0 | 4 |
_aHydrogen Peroxide _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitroprusside _xpharmacology |
| 650 | 0 | 4 |
_aOxidants _xpharmacology |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aPenicillamine _xanalogs & derivatives |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aS-Nitroso-N-Acetylpenicillamine |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aSulfhydryl Reagents _xpharmacology |
| 650 | 0 | 4 |
_aTryptophan Hydroxylase _xantagonists & inhibitors |
| 700 | 1 | _aArthur, R E | |
| 773 | 0 |
_tJournal of neurochemistry _gvol. 68 _gno. 4 _gp. 1495-502 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1471-4159.1997.68041495.x _zAvailable from publisher's website |
| 999 |
_c9068977 _d9068977 |
||